• Biology
  • Published 2014

Development of Pneumolysin as a vaccine candidate

@inproceedings{Mughal2014DevelopmentOP,
  title={Development of Pneumolysin as a vaccine candidate},
  author={Muhammad Kashif Mughal},
  year={2014}
}
More than 90 serotypes of Streptococcus pneumoniae are responsible for causing a number of invasive and non-invasive diseases in humans. To combat this pathogen there are two types of vaccines available namely pneumococcal polysaccharide vaccine (PPV) and pneumococcal conjugate vaccine (PCV). Although these vaccines have reduced the incidence and prevalence of pneumococcal diseases yet these vaccines are unable to curb the disease and have some potential drawbacks. The problems associated with… CONTINUE READING

Citations

Publications citing this paper.

Red Blood Cell Susceptibility to Pneumolysin

  • The Journal of Biological Chemistry
  • 2016
VIEW 2 EXCERPTS
CITES BACKGROUND & METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 174 REFERENCES

The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion

  • The Journal of experimental medicine
  • 2009
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

The pathogenesis of streptococcal infections: From tooth decay to meningitis

T. J. Mitchell
  • Nature Reviews Microbiology
  • 2003
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL